Synthetic BiologyThe FASEB JournalPeer-reviewed
Olaparib and Enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling
Jie Zhao, Yin Sun, Hui Min Lin…·Chawnshang Chang
This study shows that combining Olaparib and Enzalutamide synergistically suppresses HCC progression by targeting AR-mediated miR-146a-5p/BRCA1 signaling.
31 citations